These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1372368)

  • 1. Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide.
    Doel TR; Doel CM; Staple RF; DiMarchi R
    J Virol; 1992 Apr; 66(4):2187-94. PubMed ID: 1372368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.
    Doel TR; Gale C; Do Amaral CM; Mulcahy G; Dimarchi R
    J Virol; 1990 May; 64(5):2260-4. PubMed ID: 2157884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus.
    Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies elicited by a biosynthetic peptide related to a major immunogenic area of FMDV A12.
    Borca MV; Moore DM; Srikumaran S; Morgan DO
    Viral Immunol; 1990; 3(2):147-60. PubMed ID: 1694429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
    Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
    Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.
    Francis MJ; Hastings GZ; Clarke BE; Brown AL; Beddell CR; Rowlands DJ; Brown F
    Immunology; 1990 Feb; 69(2):171-6. PubMed ID: 2155177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.
    Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV
    Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective anti-peptide antibody against the immunodominant site of the A24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence.
    Barnett PV; Pullen L; Staple RF; Lee LJ; Butcher R; Parkinson D; Doel TR
    J Gen Virol; 1996 May; 77 ( Pt 5)():1011-8. PubMed ID: 8609466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological prospects for peptide vaccines against foot-and-mouth disease virus.
    Parry NR; Ouldridge EJ; Barnett PV; Clarke BE; Francis MJ; Fox JD; Rowlands DJ; Brown F
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2919-30. PubMed ID: 2479714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
    Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
    J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
    Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
    Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
    Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
    Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immune response to 16 kDa immunoreactive recombinant protein encoding the C-terminal VP1 portion of Foot and Mouth Disease Virus type Asia 1.
    Bayry J; Prabhudas K; Gopalakrishna S; Patil PK; Ramakrishna C; Misra LD; Suryanarayana VV
    Microbiol Immunol; 1999; 43(8):765-71. PubMed ID: 10524794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New virus-specific T-helper epitopes of foot-and-mouth disease viral VP1 protein.
    Volpina OM; Gelfanov VM; Yarov AV; Surovoy AYu ; Chepurkin AV; Ivanov VT
    FEBS Lett; 1993 Oct; 333(1-2):175-8. PubMed ID: 7693508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection.
    Borrego B; Novella IS; Giralt E; Andreu D; Domingo E
    J Virol; 1993 Oct; 67(10):6071-9. PubMed ID: 7690417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
    Grigera PR; Garcia-Briones M; Periolo O; la Torre JL; Wagner RR
    J Virol; 1996 Dec; 70(12):8492-501. PubMed ID: 8970972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22.
    Bolwell C; Parry NR; Rowlands DJ
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():727-31. PubMed ID: 1312129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
    Krebs O; Ahl R; Straub OC; Marquardt O
    Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.